MGMT and neoplasm: Furthermore, the hypermethylated phenotype of SDHB-related tumours apparently affects the promoter of the MGMT gene encoding the O6-methylguanine-DNA methyltransferase, the repression of which is a biomarker of a good response to alkylating agents such as temozolomide [68,69].